Product NDC: | 61755-005 |
Proprietary Name: | EYLEA |
Non Proprietary Name: | aflibercept |
Active Ingredient(s): | 40 mg/mL & nbsp; aflibercept |
Administration Route(s): | INTRAVITREAL |
Dosage Form(s): | INJECTION, SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 61755-005 |
Labeler Name: | Regeneron Pharmaceuticals, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | BLA125387 |
Marketing Category: | BLA |
Start Marketing Date: | 20111121 |
Package NDC: | 61755-005-02 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) > .05 mL in 1 VIAL, SINGLE-USE |
NDC Code | 61755-005-02 |
Proprietary Name | EYLEA |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (61755-005-02) > .05 mL in 1 VIAL, SINGLE-USE |
Product NDC | 61755-005 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | aflibercept |
Dosage Form Name | INJECTION, SOLUTION |
Route Name | INTRAVITREAL |
Start Marketing Date | 20111121 |
Marketing Category Name | BLA |
Labeler Name | Regeneron Pharmaceuticals, Inc. |
Substance Name | AFLIBERCEPT |
Strength Number | 40 |
Strength Unit | mg/mL |
Pharmaceutical Classes |